Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
LAS VEGAS, Nov. 13, 2017 -- Global Synthetic Biology Market refers to interdisciplinary area used for creating new biological parts, devices, and systems with the help of engineering principles. It can be used to develop bio-products, advanced biofuels, renewable materials, and bio-based specialty chemicals. Synthetic biology can be used to identify and catalog standardized genomic parts which can be synthesized quickly and used to build novel biological systems. In natural product synthesis, synthetic biology can be used to produce necessary enzymes along with biological functions to carry out complex multi-stage production of natural products. In biofuels, synthetic biology can be used for optimization of genes and microorganisms to efficiently convert feedstock into biofuels. Synthetic biology is anticipated to witness adoption in varied industries such as agriculture, energy, pharmaceuticals, and chemicals. In medicine, synthetic biology can be used for manufacturing of drugs, diagnostic agents and vaccines and in creation of new tissues. In chemical industry, synthetic biology can be used in the production of fine or bulk chemicals such as proteins to provide a substitute to existing synthetic fibers or natural fibers.
Reduction in the cost of DNA sequencing, rise in the development of genetically engineered crops, increased research and development related expenditure of biotechnology and pharmaceutical companies, growing demand for synthetic genes are set to drive this market. On the other hand, stringent regulations related to bio-safety & bio-security can restrict the growth of this market.
Get sample of this report: http://www.crystalmarketresearch.com/report-sample/HC06129
In 2016, enabled product segment occupied the major share of the global synthetic biology market owing to growing demand for higher-value specialty products. Besides, core product will grow at highest CAGR during the forecast period owing to increasing use of synthetic genes and development of DNA constructs. Healthcare segment occupied the major share of the overall synthetic biology market in 2016 owing to high usage in developing economical drugs and vaccines.
In 2016, Europe occupied the major share of the synthetic biology market owing to rising government funding and increased R&D efforts. On the other hand, Asia-Pacific is projected to witness significant growth in the forecast period.
Strategic collaboration is the key strategy adopted by the leading players in the market. For instance, in May 2017, Oxford Genetics (a leading synthetic biology-based technology company) entered into a non-exclusive licensing agreement with ERS Genomics. This agreement grants Oxford Genetics to access ESR’s foundational intellectual property about CRISPR/Cas9 gene editing technology. Similarly, in May 2016, Bayer and ESR Genomics entered into a patent license agreement. As per the terms of agreement, Bayer obtained access to ESR’s genome editing patent portfolio (i.e. CRISPR-Cas9) for cross divisional applications in its strategic business areas.
Leading Players in the Global Synthetic Biology Market
- New England Biolabs Inc.
- Synthetic Genomics Inc.
- Integrated DNA Technologies Inc.
- DuPont
- Amyris Inc.
- GenScript
- Intrexon Corporation
- Gingko Bioworks
- Thermo Fisher Scientific Inc.
- Intrexon Corporation
- Agilent Technologies Inc.
Buy Report: http://www.crystalmarketresearch.com/checkout/HC06129
Key Findings of the Research Study:
- Enabled product segment accounted for the largest share of the overall market in 2016
- Core product category is poised to be the fastest-growing segment during the forecast period
- Europe dominated the global market for synthetic biology in 2016 due to increased R&D efforts for the development of synthetic biology products
- Asia-Pacific is expected to grow at double digit CAGR during the forecast period due to high demand for synthetically manufactured crops and rising awareness about synthetic biology
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: + 1-888-213-4282
Email: [email protected]
Website: http://www.crystalmarketresearch.com
